|
⚲
|
| Keyboard |
| Jover Placid
✚
|
|
|---|---|
| CIK # | 0002026165 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002026165] | |
| 4 | [0002026165] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Jover Placid | |
| Teva Pharmaceutical Industries Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Option exercise | 14,150 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Sell | 14,150 | $31.67 | 448,130 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-05 | Option exercise | 14,150 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Grant | 37,982 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2025-08-01 | Option exercise | 12,827 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-08-01 | Sell | 6,053 | $15.16 | 91,763 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-08-01 | Option exercise | 12,827 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2025-03-05 | Grant | 56,603 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2024-08-01 | Grant | 51,311 | $0.00 |